MiNK Therapeutics, Inc. Profile Avatar - Palmy Investing

MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated dis…

Biotechnology
US, New York [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of INKT's Analysis
CIK: 1840229 CUSIP: 603693102 ISIN: US6036931029 LEI: - UEI: -
Secondary Listings
INKT has no secondary listings inside our databases.